The Private Equity Stakeholder Project issued a report Monday calling for increased government oversight of joint ventures between private equity firms and non-profit healthcare providers [1].
This push for regulation comes as private equity firms increasingly integrate themselves into the U.S. healthcare system. The report suggests that these partnerships may prioritize profit over patient care, potentially undermining the mission of non-profit institutions.
According to the Private Equity Stakeholder Project, the growing number of these joint ventures creates specific risks for patients, payers, and employees [1]. The group said that the current lack of oversight allows private equity firms to exert influence over clinical decisions and pricing structures without sufficient transparency.
These joint ventures often involve a private equity firm providing capital or management expertise in exchange for a share of the profits from a specific healthcare service line. While this model can provide non-profits with necessary funding, the watchdog group said that it can also lead to a degradation of care standards.
Government regulators have historically focused on full acquisitions of healthcare facilities. However, the report highlights that joint ventures offer a different pathway for private equity to enter the market—one that may currently bypass many traditional regulatory checks [1].
The Private Equity Stakeholder Project said that the federal government must implement stricter reporting requirements to track these partnerships. Such measures would allow regulators to monitor how these deals affect the cost of care and the quality of services provided to the public [1].
Without these safeguards, the organization said that the U.S. healthcare system remains vulnerable to the incentives of private equity, which often prioritize short-term financial gains over long-term community health outcomes [1].
“The report suggests that these partnerships may prioritize profit over patient care.”
The shift toward joint ventures represents a strategic pivot for private equity, allowing them to gain a foothold in healthcare without the regulatory scrutiny associated with full acquisitions. If the U.S. government adopts the recommendations of the Private Equity Stakeholder Project, it could lead to new disclosure laws and a tighter restriction on how non-profit hospitals partner with for-profit investment firms.
